Carl Sailer - 23 Nov 2021 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role: Director
Signature: /s/ Kostantinos Skordalos, Power of Attorney For: Carl V. Sailer
Issuer symbol: ACXP
Transactions as of: 23 Nov 2021
Transactions value $: $24,979
Form type: 4
Filing time: 24 Nov 2021, 15:06:28 UTC
Previous filing: 06 Jul 2021
Next filing: 29 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACXP	Common Stock	Purchase	$25K	+5.16K	+7.6%	$4.84	73.1K	23 Nov 2021	Direct	F1
holding	ACXP	Common Stock						5K	23 Nov 2021	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.73 to $4.86 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.

Content

The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.73 to $4.86 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.